Salsalate as an Adjunctive Treatment for Patients With Schizophrenia

Summary

This is a 12-week, open-label trial of salsalate 3 g/day as an adjunctive treatment in 15 schizophrenia subjects to examine salsalate's effect on psychopathology, cognitive functioning, and metabolic parameters. Potential subjects will be identified by their clinicians at the Freedom Trail Clinic, or Massachusetts General Hospital. A total of 15 subjects will be enrolled.

Timeline

Start

2011-06

Primary completion

2015-07

Completion

2015-07

Drugs

Indications